简介
Education
1972 - 1976: B.Sc. University of Amsterdam, medical biology
1976 - 1980: M.Sc. University of Amsterdam (cum laude)
1980 - 1984: Ph.D. University of Leiden (cum laude)
Thesis title: Transformation and oncogenicity by human adenoviruses.
Alex van der Eb, thesis advisor.
Postdoctoral training
1985 - 1988 Postdoctoral fellow, Whitehead Institute for Biomedical Research,
Cambridge, MA, USA. Robert Weinberg, advisor.
Positions held
1988 - 1994 Assistant Professor, Harvard University.
1992 - present: Division of Molecular Carcinogenesis, Netherlands Cancer
Institute, Amsterdam.
1994 - present Professor of Molecular Carcinogenesis Utrecht University (part time).
2003 - present Co-founder and Chief Scientific Officer, Agendia NV, Amsterdam, The Netherlands (part time).
2015- present Co-founder Qameleon Therapeutics BV, The Netherlands (part time).
Professional Societies
Member: European Molecular Biology Organization (EMBO)
American Association for Cancer Research (AACR)
Netherlands Foundation for Biochemistry and Molecular Biology
Royal Dutch Academy of Arts and Sciences (KNAW)
Honors and Awards
1985: Constantijn and Christiaan Huygens Fellowship, Netherlands
Organization for Scientific Research.
1988: Edward Mallinckrodt Foundation award.
1989: Searle Scholarship award.
1992: Pionier Award, Netherlands Organization for Scientific Research.
2004: Josephine Nefkens award, Erasmus University, Rotterdam.
2005: Pezcoller Foundation-FECS Recognition for Contribution to
Oncology.
2005: Member, Academia Europea.
2005: Spinoza award, Netherlands Organization for Scientific Research.
2005: Ernst W. Bertner Award for Cancer Research, M.D. Anderson Cancer
Center.
2007: Member, Royal Netherlands Academy of Arts and Sciences.
2007: ESMO Lifetime Achievement Award in Translational Research in
Breast Cancer.
2009 Fellow, European Academy of Cancer Sciences.
2011 Scrip Best Partnership Alliance Award for colorectal cancer
collaboration with AstraZeneca and Agendia.
2012 Queen Wilhelmina Research Prize, Dutch Cancer Society.
2013 Academy Professor Prize, Royal Netherlands Academy of Arts and Sciences.
2018 Fellow of the AACR academy
2019 International Honorary member, American Academy of Arts and Sciences
2020 International member, National Academy of Science
2022 Princess Takamatsu Memorial Lectureship, AACR.
2024 Member, Royal Holland Society of Sciences and Humanities (KHMW).
2024 Foreign Member, Royal Society.
2024 Shanghai science and technology international collaboration award.
2024 Huaxia International Award for Medical Cooperation and Promotion.
Committees, Advisory Boards and consultancies
2012 - present Chair, Pezcoller Foundation-AACR International Award for Cancer Research Selection Committee.
2012 – present Member Scientific Advisory Board, SiRIC of the Institut Curie, Paris.
2013 - present Co-Chairperson of the 2013-2015 AACR Laboratory Research Awards Committee.
2014 – present Member Scientific Committee Louis Jeantet Foundation.
2014 – 2017 Member AACR Nomination Committee.
2014 – 2017 Member AACR special conferences committee.
2014 – present Member AACR publications committee
2015 – 2019 Consultant, Genentech, South San Francisco, USA
2016 – 2024 Member, Scientific Advisory Board, Hartwig Medical Foundation
2017 – present Member, Cancer Grand Challenge Scientific committee
2018 – 2021 Member, AACR board of directors
2018 – 2022 Member supervisory board Hubrecht Organoid Bank
2019 – 2022 President-elect EACR
2021 – present Consultant Amphista Ltd. UK
2021 – 2025 Consultant Abxis, Korea
2021 – present Member Scientific Advisory Board, Roche China Innovation Center, Shanghai, China
2022 Chair, AACR Tellers Committee
2022 – present Member, board of directors Lixte Holdings Ltd.
2022 – 2024 President European Association for Cancer Research (EACR)
2023 – present Member Scientific Advisory Board, Erasca.
2022 – present Member, Scientific Advisory Board ISREC, Lausanne, Switzerland
2024 – 2026 Past president European Association for Cancer Research (EACR)
